Vivos Inc Stock Investor Sentiment

RDGL Stock  USD 0.12  0.01  9.09%   
About 55% of Vivos' institutional investors are presently thinking to get in. The analysis of current outlook of investing in Vivos Inc suggests that some traders are interested regarding Vivos' prospects. Vivos' investing sentiment shows overall attitude of investors towards Vivos Inc.
Vivos otc stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Vivos daily returns and investor perception about the current price of Vivos Inc as well as its diversification or hedging effects on your existing portfolios.
  
few days ago at news.google.com         
Short Interest in Vivos Inc. Drops By 67.8 percent - MarketBeat
Google News at Macroaxis
over three weeks ago at news.google.com         
Vivos Inc. Short Interest Update - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
Cancer Breakthrough Vivos RadioGel Eliminates 80 percent of Tumor Mass in Groundbreaking Trial - Sto...
Google News at Macroaxis
over a month ago at news.google.com         
Short Interest in Vivos Inc. Drops By 61.0 percent - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
Vivos Inc. Sees Significant Decrease in Short Interest - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
US Penny Stocks To Watch In January 2025 - Simply Wall St
Google News at Macroaxis
over two months ago at news.google.com         
Vivos Inc. Short Interest Update - MarketBeat
Google News at Macroaxis
over two months ago at news.google.com         
After Leaping 35 percent Vivos Therapeutics, Inc. Shares Are Not Flying Under The Radar - Simply Wal...
Google News at Macroaxis
over two months ago at news.google.com         
Vivos Inc.s IsoPet Division Achieves Exceptional Growth in 2024, Expanding Certified Veterinary Clin...
Google News at Macroaxis
over two months ago at news.google.com         
Vivos Launches Breakthrough RadioGel Cancer Trial First 5 Patients Show Promising Results - StockTit...
Google News at Macroaxis
over two months ago at news.google.com         
Celsius Holdings Inc Quote - Press Release - The Globe and Mail
Google News at Macroaxis
over three months ago at news.google.com         
Even With A 27 percent Surge, Cautious Investors Are Not Rewarding Vivos Therapeutics, Inc.s Perform...
Google News at Macroaxis
over three months ago at news.google.com         
Vivos CEO Michael Korenko acquires 7,080 in common stock - Investing.com
Google News at Macroaxis
over three months ago at news.google.com         
Vivos Inc. Certifies New Clinic for IsoPet Precision Radionuclide TherapyTM - Marketscreener.com
Google News at Macroaxis
over three months ago at news.google.com         
Vivos CEO buys 7955 worth of company stock at 0.1591 each - Investing.com Canada
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Vivos that are available to investors today. That information is available publicly through Vivos media outlets and privately through word of mouth or via Vivos internal channels. However, regardless of the origin, that massive amount of Vivos data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Vivos news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Vivos relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Vivos' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Vivos alpha.

Vivos Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Other Information on Investing in Vivos OTC Stock

Vivos financial ratios help investors to determine whether Vivos OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vivos with respect to the benefits of owning Vivos security.